Ebitda változás Dátum
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Aceragen USD -7440000 1.14M 2023-03
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amgen USD 3.66B 713M 2023-12
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bluebird Bio USD -83657000 670K 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Exelixis USD -11287000 95.18M 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
Incyte USD 226.99M 9.73M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Merck USD 7.51B 11.02B 2023-09
Moderna USD 209M 1.97B 2023-12
Nektar Therapeutics USD -31809000 70K 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Incyte - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.